2009

• 08/01/2009

  Ablynx strengthens management team with the appointment of Dr Debbie Law as Chief Scientific Officer

• 09/01/2009

  CoreValve Prevails in United Kingdom Patent Infringement Action

• 13/01/2009

  Inside Contactless Named “Red Herring 100 Global” Finalist

• 13/01/2009

  Thomas Gebauer joins ReVolt Technology, Ltd as CFO

• 14/01/2009

  Ablynx announces technical advances in its NANOBODY® platform technology: enhanced benefits from pulmonary delivery and half-life extension

• 15/01/2009

  ReVolt Technology, Ltd Receives Additional 10 Million Euro B Round Investment

• 16/01/2009

  Purple Labs Closes 52 Million Euro License And Development Agreement Following Acquisition Of Sagem Mobile Software

• 20/01/2009

  ReVolt Technology, Ltd Forms Technical Advisory Board

• 21/01/2009

  Ablynx expands its musculoskeletal portfolio by taking P&G pharmaceuticals' programme in-house

• 21/01/2009

  Vivalis and Innate Pharma sign a collaboration and commercial license agreement to develop Innate's novel monoclonal antibody, to be manufactured with vivalis'EB66® platform, for rare cutaneous cancers

• 21/01/2009

  DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor

• 21/01/2009

  Vivalis et Innate Pharma signent un accord de collaboration et de licence commerciale pour le développement d'un nouvel anticorps d'Innate produit sur la plateforme EB66® pour le traitement de cancers cutanés rares

• 22/01/2009

  Emailvision, 1er éditeur international des logiciels «SaaS» pour la gestion et l’optimisation des campagnes d’e-mail marketing, publie son chiffre d’affaires 2008.

• 28/01/2009

  Addex Successfully Completes ADX48621 Phase I Program

• 28/01/2009

  PC 30 - journal télévisé France 2 - 26 déc

• 04/02/2009

  Inside Contactless and Sagem Wireless extend NFC Technology Partnership

• 05/02/2009

  String of Achievements Reinforces Company’s Leadership Role

• 11/02/2009

  NFC Technology Part of Qualcomm 3G Handset Reference Designs,

• 13/02/2009

  Esmertec to acquire Purple Labs creating Europe’s largest mobile phone software company

• 23/02/2009

  Sofinnova Partners realizes impressive exit with sale of portfolio company CoreValve to Medtronic

• 23/02/2009

  Sofinnova Partners réussit la sortie de CoreValve : vente à Medtronic pour un montant initial de 700 millions de dollars

• 17/02/2009

  Tech tour seeks 'Best of French' emerging technology companies

• 05/03/2009

  GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners

• 05/03/2009

  GlycoVaxyn AG lève CHF 25 Million d’argent frais

• 03/03/2009

  Novexel’s NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients with complicated Intra- Abdominal Infections (cIAIs)

• 03/03/2009

  Novexel débute une deuxième étude clinique de phase II sur l’association NXL104/ceftazidime chez des patients hospitalisés atteints d’infections intra-abdominales compliquées

• 10/03/2009

  EOS (Ethical Oncology Science) Closes an € 8.2 Million (US$ 10 Million) Series A Financing to Advance Innovative Targeted Cancer Therapies 

• 12/03/2009

  Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform,solving stent-malapposition

• 17/03/2009

  PC30 annonce le rachat de la société SMARTFIX aux Pays-Bas

• 25/03/2009

  Sofinnova Partners Voted 2008 “European Venture Capital Firm of the Year”

• 25/03/2009

  Sofinnova Partners élu « Société de capital-risque européenne de l'année 2008 »

• 30/03/2009

  Ablynx reports detailed positive phase Ib results for its anti-thrombotic Nanobody® ALX-0081

• 31/03/2009

  First Data and Inside Contactless launch partnership for go-tag payment sticker technology

• 02/04/2009

  Paris, le 2 avril 2009 - PC30 | Comptes 2008

• 08/04/2009

  PC30 - Challenges

• 15/04/2009

  Travel technology leader Sprice.com to power Sify's travel search

• 20/04/2009

  UPEK and WinMagic Announce Biometric Authentication and Hard Disk Encryption Solution for SMBs Eikon Fingerprint Reader ...

• 13/04/2009

  PC 30 | ITÉLÉ 13 AVRIL 09 20H30-21H - Vive les entreprises de service ?

• 21/04/2009

  Neosens closes a second funding round of €4M

• 27/04/2009

  Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy

• 27/04/2009

  Innate Pharma nomme le Docteur Rozencweig au poste de Senior Vice Président, stratégie clinique et réglementaire

• 29/04/2009

  LITTLETON, Colorado, April 29, 2009 – CPI Card Group (CPI), a global leader in financial and commercial card production and services, and INSIDE Contactless, a leading provider of advanced, open-standard contactless chip technologies, today announced they

• 07/05/2009

  Ablynx announces that its VWF NANOBODY® programme has been granted orphan drug designation and provides a business update for the first quarter 2009

• 11/05/2009

  HRA pharma and Preglem announce successful completion of phase IIB for ulipristal acetate for the treatment of uterine fibroids

• 15/05/2009

  UPEK Wins TiE50 Award

• 27/05/2009

  U.S. Bank first to offer a single visa card for identification, purchases and secure facility access

• 28/05/2009

  Inside debuts converged contactless payment/access control platform

• 30/05/2009

  Innate Pharma reports preliminary phase I clinical data for IPH 2101 (a novel, anti-kir monoclonal antibody activating NK celles) at the ASCO meeting

• 02/06/2009

  Consumers “Tap” Over One Million Mobile Searches Daily

• 28/05/2009

  HID Global Together with INSIDE Contactless Debut Converged Platform for Access Control and Payment Solutions

• 02/06/2009

  Myriad Group AG announces Q1 revenue of USD 30 million

• 02/06/2009

  UPEK Unveils Fingerprint Sensor with Integrated LEDs

• 08/06/2009

  NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer®

• 19/06/2009

  ReVolt Technology Selected as a Top-24 European Cleantech Leader

• 18/06/2009

  Sprice.Com Teams Up With AsiaOne

• 22/06/2009

  blueKiwi lève 3 millions d'euros auprès de Dassault Systèmes

• 23/06/2009

  Takeda Establishes "Takeda Global Advisory Board"

• 22/06/2009

  Sofinnova Partners Leads Investment Round in CoAxia

• 26/06/2009

  Ablynx wins european mediscience award for best technology

• 29/06/2009

  Innate Pharma reports positive phase IIa clinical results for IPH 1101 (ãä T CELL AGONIST) in type C viral hepatitis

• 29/06/2009

  Innate Pharma annonce des r¨¦sultats de phase IIa positifs avec IPH 1101 (agonistedes lymphocytes T ¦Ã¦Ä) dans l'h¨¦patite virale de type C

• 02/07/2009

  PC30 reprend les activités « desktop » de SOGETI en Ile de France

• 02/07/2009

  Ablynx promoted to the belgian MID-CAP-INDEX

• 06/07/2009

  Blue Kiwi | The Europas Shortlist: Best Enterprise / B2B Startup

• 08/07/2009

  Stentys receives CE Mark approval

• 09/07/2009

  ReVolt Technology, Ltd & BASF Announce Joint Development Agreement for Rechargeable Zinc-Air Battery

• 09/07/2009

  Maurice Petitou, Directeur de la Recherche chez Endotis Pharma, Lauréat du Prix Charles Mentzer pour ses découvertes et le développement d’oligosaccharides de synthèses dans la maladie thromboembolique

• 09/07/2009

  Maurice Petitou, Head of Preclinical Research & Development at Endotis Pharma, wins the Charles Mentzer Prize for his discoveries on synthetic oligosaccharides in thrombosis

• 15/07/2009

  INTERAC® Partners with Global Leader INSIDE to bring Contactless Debit to Canada

• 27/07/2009

  Movetis receives positive opinion by the CHMP on European Marketing Authorisation Application for Resolor® (prucalopride) indicated for the treatment of Chronic Constipation

• 27/07/2009

  Orange to offer free gifts to students who agree to receive ads on mobiles

• 21/07/2009

  Multek Enhances Touch Screen Solution Through Sensitive Object Strategic Alliance

• 30/07/2009

  EOS (Ethical Oncology Science) Closes Series A Financing with new Investor AESCAP Venture joining Sofinnova Partners and Quantica SGR

• 30/07/2009

  Renforcement du conseil de surveillance de PC30 Jean Marie Descarpentries nommé Président

• 13/08/2009

  Inside Contactless and cryptography research sign agreement to license DPA patents

• 12/08/2009

  Upek launches developer contest for Windows 7 Biometric applications

• 12/08/2009

  Richard L. Middaugh Joins ReVolt Technology Advisory Board

• 18/08/2009

  Orexo announces that its partner Meda has initiated the launch of EdluarTM in the USA

• 18/08/2009

  Ablynx announces positive Phase I results for subcutaneous administration of its ANTI-THROMBOTIC NANOBODY® (ALX-0681)

• 18/08/2009

  Myriad Delivers Services Platform for Customer Service to T-Mobile

• 27/08/2009

  Ablynx announces half-year results for 2009

• 28/08/2009

  Orexo signs exclusive worldwide license agreement for a novel formulation

• 27/08/2009

  Start of the first phase II clinical trial with monoclonal antibody IPH 2101 supported by a new 2.9 millions euros financing from OSEO

• 28/08/2009

  Stentys appoints Vice President of Sales and Marketing

• 01/09/2009

  ReVolt Technology Applies for $30 million in Government Research Grants Accelerating Development of Innovative Zinc-Air Batteries for Vehicles and Renewable Energy Storage Company selects Portland, Oregon as location for US HQ & R&D Center

• 01/09/2009

  Ablynx inititates Phase II clinical trial for ALX-0081

• 03/09/2009

  NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12

• 01/09/2009

  Myriad Appoints James Bodha as New Chief Financial Officer

• 08/09/2009

  Inside Contactless and Connecthings team to take NFC to the next level

• 09/09/2009

  ReVolt Technology named a Global Cleantech 100 clean technology company

• 09/09/2009

  Neosens named a Global Cleantech 100

• 10/09/2009

  SFR a sélectionné WYPLAY pour sa prochaine génération de décodeurs TV

• 10/09/2009

  SFR selects WYPLAY for its next generation of HD IP-STB

• 09/09/2009

  Engel and Wyplay parnter for next generation connected HD STB

• 11/09/2009

  Myriad Introduces World’s First Widget Solution for Ultra-Low Cost Mobile Phones

• 14/09/2009

  Stentys to disclose results of 'APPOSITION I' clinical study, world's first to treat acute myocardial infarction (AMI) with a self-expanding stent

• 14/09/2009

  Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)

• 15/09/2009

  Myriad Group Acquires Xumii, Inc.

• 22/09/2009

  Myriad Appoints Former Nokia Chief Technologist Benoit Schillings as Chief Technical Officer

• 22/09/2009

  UPEK Expands Biometric Market with Launch of New TouchChip® Fingerprint Solutions

• 23/09/2009

  Myriad Group Reports EBITDA of USD 11 Million for 2009 H1

• 28/09/2009

  Addex complète le recrutement d’un premiere essai clinique intermédiare sur le RGO

• 28/09/2009

  Addex completes enrollment of first mid-stage clinical GERD trial

• 28/09/2009

  Upek launches new product line optimized for mobile phone applications

• 01/10/2009

  CONNECTHINGS, INSIDE Contactless and Sagem Wireless Receive Grant from French Government for First Wave-Me Services

• 01/10/2009

  Sofinnova Partners annonce un accord portant sur la cession de Fovea Pharmaceuticals à Sanofi Aventis

• 01/10/2009

  Sofinnova Partners announces an agreement to sell Fovea Pharmaceuticals to Sanofi Aventis

• 01/10/2009

  Ablynx receives milestone payment as part of its strategic alliance with Boehringer Ingelheim

• 06/10/2009

  PUMA partners with Sagem Wireless to launch PUMA Mobile Phone

• 06/10/2009

  Orexo confirms FDA acceptance of Abstral filing

• 12/10/2009

  Crescendo Biologics Raises £4.5 million in Seed-Funding Led by Sofinnova Partners

• 12/10/2009

  NOXXON Pharma AG announces excellent preliminary phase I trial results for Spiegelmer® NOX-E36 - good safety and pharmacodynamic profile and additional good subcutaneous bioavailability

• 12/10/2009

  Ablynx and Domantis settle their dispute and stop the arbitration process

• 15/10/2009

  Protector Suite 2009 Software Adds Support for Windows 7 and the Windows Biometric Framework

• 15/10/2009

  MicroPass 5100 “ICAO Lite” Products Compete for Best Identification Solution

• 15/10/2009

  Accent - Itron Selects Accent Single Chip Solution for Smart Metering Applications

• 16/10/2009

  Flexion Therapeutics Raises $33 Million in Series A Financing

• 19/10/2009

  Endotis Pharma has initiated a Phase I program with the neutralizable anticoagulant EP217609 and its specific antidote avidin, and signed a manufacturing and co-development agreement with Sigma-Tau for avidin

• 21/10/2009

  Largest Retail Deployment of Contactless Loyalty Sticker Technology in France

• 22/10/2009

  Movetis obtains EU authorisation for the commercialisation of Resolor® (prucalopride). First launch of Resolor anticipated in Q1 2010.

• 23/10/2009

  Le cabinet d'analystes Gartner vient de classer blueKiwi Software comme entreprise "Visionnaire" dans son Magic Quadrant 2010 sur les Réseaux Sociaux d'Entreprise ("Social Software in the Workplace 2010")

• 26/10/2009

  Sofinnova Partners Leads $12 Million Series A Round in DNP Green Technology

• 26/10/2009

  Sofinnova Partners, principal investisseur dans la première levée de fonds de 12 millions de dollars de DNP Green Technology

• 27/10/2009

  Stentys expands Scientific Advisory Board (SAB) on heels of reporting successful clinical trial results for world's first self-expanding stent to treat AMI

• 27/10/2009

  Sagem Wireless collaborates with CRYSTALLIZED™ – Swarovski Elements

• 03/11/2009

  Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference

• 03/11/2009

  Inside Contactless open Asia testing facility

• 02/11/2009

  NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12

• 02/11/2009

  Chiffre d’affaires 3ème trimestre 2009

• 16/11/2009

  Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial

• 18/11/2009

  Ablynx achieves third milestone in drug discovery and development collaboration

• 17/11/2009

  UPEK Announces EikonTouch™ USB Fingerprint Readers

• 19/11/2009

  INSIDE Contactless wins in Semiconductor, Electronic and Components Category

• 03/12/2009

  Movetis raises targeted €85 million in successful Initial Public Offering on Euronext Brussels

• 04/12/2009

  First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)

• 03/12/2009

  NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company

• 03/12/2009

  Ablynx will receive further milestone payments of €3 million as part of its strategic alliance with Boehringer Ingelheim

• 03/12/2009

  Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.

• 08/12/2009

  mydeco.com Hires Ex-Google Product Manager

• 04/12/2009

  Endotis Pharma presents Phase I clinical trials results for EP42675, a first-inclass synthetic parenteral anticoagulant, at the 51st Annual Meeting of the American Society of Hematology

• 02/11/2009

  Endotis Pharma forms a strategic alliance with Catalent Pharma Solutions for the development of oral formulations of synthetic oligosaccharides and initiates preclinical development of EP37151, a first in-class oral anticoagulant

• 14/12/2009

  Ablynx initiates Phase I for ALX-0141 (ANTI-RANKL)

• 14/12/2009

  Addex ends migraine prevention study Conference call tomorrow at 2pm CET (8am ET)

• 23/12/2009

  Sofinnova Partners annonce sa troisième cession de plus de 500 millions de dollars pour l’année 2009

• 23/12/2009

  Novexel to be acquired by AstraZeneca

• 26/11/2009

  MasterCard Canada Brings PayPass™ Payments to BlackBerry Smartphones

• 23/12/2009

  Sofinnova Partners Announces for the Third Time in 2009 a Trade Sale over 500 million dollars

• 23/12/2009

  Movetis raises a total of €97.75m via an additional €12.75 million Over-allotment Option

• 22/12/2009

  Ablynx demonstrates proof-of-concept by biomarker for its anti-thrombotic ALX-0081